Clinical trial
PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C
NCT00100659 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00100659 |
|---|---|
| Title | PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C |
| Official title | Pegylated Interferon +/- Ribavirin for Children With Hepatitis C |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Pegylated Interferon/ribavirin |
| Enrollment | 114 |
| Start date | Dec 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | Jan 5, 2005 |
| Last update posted | Oct 24, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: